Application 217813

Type
ANDA
Sponsor
TRIS PHARMA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DEFLAZACORTDEFLAZACORTSUSPENSION;ORAL22.75MG/MLNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
78598ORIG 2024-05-31